Bronchial Artery Angiogenesis Drives Lung Tumor Growth

Area of Science:

• Oncology
• Cardiovascular Biology
• Respiratory Medicine

Background:

• Angiogenesis is crucial for tumor progression, but its role in well-vascularized organs like the lung is not fully understood.
• The lung possesses dual circulations: the pulmonary and the systemic bronchial circulation, complicating the study of lung tumor growth.
• Existing animal models for non-small cell lung cancer (NSCLC) are limited, particularly in their ability to replicate the lung's complex vascular system.

Purpose of the Study:

• To investigate the distinct roles of the pulmonary and bronchial circulations in supporting non-small cell lung cancer (NSCLC) growth.
• To establish and utilize a novel orthotopic rat model for studying lung tumor vascularization.
• To explore the potential of targeting the bronchial circulation for cancer therapy.

Main Methods:

• Development of an orthotopic non-small cell lung cancer model in rats.
• Quantification of tumor vascular perfusion using fluorescent microspheres and high-resolution computed tomography (HR-CT).
• Assessment of tumor volume changes following bronchial artery ablation.

Main Results:

• Bronchial artery perfusion significantly increased with tumor growth (206% by microspheres, 276% by HR-CT), while pulmonary artery perfusion remained constant.
• Ablation of the bronchial artery led to a reduction in tumor volume over four weeks.
• Tumor initiation was supported by the pulmonary circulation, but subsequent growth depended on the bronchial circulation.

Conclusions:

• The bronchial circulation, not the pulmonary circulation, is essential for the sustained growth of non-small cell lung cancer in the lung.
• The developed rat model effectively differentiates the contributions of the lung's dual circulations to tumor progression.
• This model provides a platform for developing novel therapeutic strategies targeting the bronchial artery in lung cancer treatment.